Author:
Wang Yiwei,Shang Yuan,Mishra Aarti,Bacon Eliza,Yin Fei,Brinton Roberta
Abstract
AbstractDecline in brain glucose metabolism is a hallmark of late-onset Alzheimer’s disease (LOAD). Comprehensive understanding of the dynamic metabolic aging process in brain can provide insights into windows of opportunities to promote healthy brain aging. Chronological and endocrinological aging are associated with brain glucose hypometabolism and mitochondrial adaptations in female brain. Using a rat model recapitulating fundamental features of the human menopausal transition, results of transcriptomic analysis revealed stage-specific shifts in bioenergetic systems of biology that were paralleled by bioenergetic dysregulation in midlife aging female brain. Transcriptomic profiles were predictive of outcomes from unbiased, discovery-based metabolomic and lipidomic analyses, which revealed a dynamic adaptation of the aging female brain from glucose centric to utilization of auxiliary fuel sources that included amino acids, fatty acids, lipids, and ketone bodies. Coupling between brain and peripheral metabolic systems was dynamic and shifted from uncoupled to coupled under metabolic stress. Collectively, these data provide a detailed profile across transcriptomic and metabolomic systems underlying bioenergetic function in brain and its relationship to peripheral metabolic responses. Mechanistically, these data provide insights into the complex dynamics of chronological and endocrinological bioenergetic aging in female brain. Translationally, these findings are predictive of initiation of the prodromal / preclinical phase of LOAD for women in midlife and highlight therapeutic windows of opportunity to reduce the risk of late-onset Alzheimer’s disease.
Publisher
Springer Science and Business Media LLC
Reference89 articles.
1. Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med 367, 795–804, https://doi.org/10.1056/NEJMoa1202753 (2012).
2. Reitz, C., Brayne, C. & Mayeux, R. Epidemiology of Alzheimer disease. Nature reviews. Neurology 7, 137–152, https://doi.org/10.1038/nrneurol.2011.2 (2011).
3. Brinton, R. D. Neurosteroids as regenerative agents in the brain: therapeutic implications. Nature reviews. Endocrinology 9, 241–250, https://doi.org/10.1038/nrendo.2013.31 (2013).
4. De Santi, S. et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiology of aging 22, 529–539 (2001).
5. Ishii, K. et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer’s disease. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 38, 925–928 (1997).
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献